Sector valuations Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.870 USD | +1.77% |
|
-3.69% | +4.36% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -2.56x | 1.25x | 0.12x | 317.81x | -1.06x | -1.07x | -.--% | 322M | ||
| 32.79x | 4.38x | 1.25x | 5.87x | 17.42x | 24.43x | 1% | 47.74B | ||
| -23.47x | 18.4x | -0.68x | 352.2x | -21.51x | -21.44x | -.--% | 39.98B | ||
| 48.32x | 7.28x | 0.29x | 4.93x | 31.87x | 36.84x | -.--% | 36.23B | ||
| 25.95x | 4.92x | 5.39x | 2.85x | 12.32x | 18.77x | -.--% | 35.59B | ||
| 27.91x | 2.22x | 0.63x | 7.98x | 19.84x | 23.98x | 0.43% | 27.91B | ||
| 33.62x | 24.05x | 2.28x | 5.49x | 25.05x | 26.07x | -.--% | 16.45B | ||
| 22.1x | 2.5x | 0.62x | 1.97x | 8.54x | 13.17x | 1.19% | 13.21B | ||
| 23.86x | 1.33x | 0.17x | 1.9x | 11.51x | 13.08x | -.--% | 12.93B | ||
| 61.48x | 5.14x | 0.4x | 9.18x | 26.08x | 28.51x | 0.45% | 11.16B | ||
| -31.92x | 9.39x | 1.2x | 115.52x | -32.88x | -57.22x | -.--% | 11.1B | ||
| 36.59x | 3.28x | -0.12x | 3.28x | 12.74x | 15.55x | -.--% | 10.8B | ||
| -31.11x | 9x | -13.66x | 1001.23x | -26.54x | -26.01x | -.--% | 10.08B | ||
| 36.13x | 4.02x | 2.54x | 4.23x | 17.81x | 27.59x | 0.62% | 9.54B | ||
| -15.58x | 243.64x | -0.31x | 10.11x | -14.94x | -14.28x | -.--% | 9.25B | ||
| -31.34x | 8.04x | 6.47x | 90.28x | -20.48x | -19.8x | -.--% | 9.05B | ||
| -20.77x | 7.86x | -1.62x | 3564.45x | -17.52x | -17.06x | -.--% | 8.8B | ||
| -136.79x | 4.76x | 1.08x | 5.41x | 30.92x | 172.64x | -.--% | 8.79B | ||
| 31.91x | - | -0.1x | 15.37x | 28.5x | 28.66x | -.--% | 8.72B | ||
| Average | 4.58x | 20.08x | 0.31x | 290.53x | 5.67x | 14.34x | 0.19% | 17.25B | |
| Weighted average by Cap. | 13.60x | 14.60x | 0.77x | 180.48x | 8.55x | 14.99x | 0.26% |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















